Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-31
DOI
10.1007/s40265-018-0971-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial
- (2018) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Prostaglandin E2 and IL-23 interconnects STAT3 and RoRγ pathways to initiate Th17 CD4+ T-cell development during rheumatoid arthritis
- (2018) Janaiya S. Samuels et al. INFLAMMATION RESEARCH
- Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients
- (2018) Walter P Maksymowych et al. RHEUMATOLOGY
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathogenesis of psoriasis and development of treatment
- (2017) Eisaku Ogawa et al. JOURNAL OF DERMATOLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNFα, induces robust activation and a phenotypic switch of ILC3
- (2017) Amanda M. Schmidt Paustian et al. PLoS One
- Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity
- (2017) Jeongsu Do et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-17 Signaling: The Yin and the Yang
- (2017) Nilesh Amatya et al. TRENDS IN IMMUNOLOGY
- Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study
- (2017) H. Marzo-Ortega et al. ARTHRITIS CARE & RESEARCH
- An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting)
- (2017) Muhammad A. Khan Current Rheumatology Reports
- Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA-B27 Activates the Unfolded Protein Response
- (2017) Zhenbo Zhang et al. Arthritis & Rheumatology
- Polymorphisms in the F Pocket of HLA-B27 Subtypes Strongly Affect Assembly, Chaperone Interactions, and Heavy-Chain Misfolding
- (2017) David B. Guiliano et al. Arthritis & Rheumatology
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Genetic Variants in ERAP1 and ERAP2 Associated With Immune-Mediated Diseases Influence Protein Expression and the Isoform Profile
- (2017) Aimee L. Hanson et al. Arthritis & Rheumatology
- Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study
- (2016) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
- (2016) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
- (2016) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis
- (2016) Eric Gracey et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group
- (2016) Robert G W Lambert et al. ANNALS OF THE RHEUMATIC DISEASES
- Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease
- (2016) Marianne Forkel et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
- (2016) Mark Corbett et al. HEALTH TECHNOLOGY ASSESSMENT
- Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis
- (2016) E. Hayashi et al. JOURNAL OF RHEUMATOLOGY
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
- (2016) David Ellinghaus et al. NATURE GENETICS
- Ankylosing Spondylitis and Axial Spondyloarthritis
- (2016) Joel D. Taurog et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B27 Anterior Uveitis: Immunology and Immunopathology
- (2016) Denis Wakefield et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
- (2016) M. Rudwaleit et al. ARTHRITIS CARE & RESEARCH
- IL-17-producing γδ T cells enhance bone regeneration
- (2016) Takehito Ono et al. Nature Communications
- Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berl
- (2016) Susanne J. Pedersen et al. Arthritis & Rheumatology
- Functional Interaction of the Ankylosing Spondylitis-Associated Endoplasmic Reticulum Aminopeptidase 2 With the HLA-B*27 Peptidome in Human Cells
- (2016) Adrian Martín-Esteban et al. Arthritis & Rheumatology
- Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice
- (2016) Annika Reinhardt et al. Arthritis & Rheumatology
- Brief Report:Dialisteras a Microbial Marker of Disease Activity in Spondyloarthritis
- (2016) Raul Y. Tito et al. Arthritis & Rheumatology
- The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
- (2016) Verena Katharina Raker et al. Frontiers in Immunology
- Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease
- (2016) Philip C Robinson et al. npj Genomic Medicine
- MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis
- (2015) Pedro M Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis
- (2015) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- HLA-B27
- (2015) Paul Bowness Annual Review of Immunology
- IL-27-induced modulation of autoimmunity and its therapeutic potential
- (2015) Rakeshchandra R. Meka et al. AUTOIMMUNITY REVIEWS
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1
- (2015) Adrian Cortes et al. Nature Communications
- A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
- (2015) J. Sieper et al. Arthritis & Rheumatology
- American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- (2015) Michael M. Ward et al. Arthritis & Rheumatology
- Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis
- (2015) Mary-Ellen Costello et al. Arthritis & Rheumatology
- Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study
- (2015) Fiona Maas et al. PLoS One
- Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
- (2014) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity
- (2014) P.H. Schafer et al. CELLULAR SIGNALLING
- Tc17 Cells in Immunity and Systemic Autoimmunity
- (2014) Yan Liang et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- The changing clinical picture and epidemiology of spondyloarthritis
- (2014) Astrid van Tubergen Nature Reviews Rheumatology
- Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
- (2014) C. Bao et al. RHEUMATOLOGY
- The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis--a randomized, placebo-controlled pilot trial
- (2014) L.-S. Tam et al. RHEUMATOLOGY
- IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities
- (2014) D. T. S. L. Jansen et al. RHEUMATOLOGY
- Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- (2014) Maxime Dougados et al. Arthritis & Rheumatology
- Fat Metaplasia and Backfill Are Key Intermediaries in the Development of Sacroiliac Joint Ankylosis in Patients With Ankylosing Spondylitis
- (2014) Walter P. Maksymowych et al. Arthritis & Rheumatology
- Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice
- (2014) Helen Benham et al. Arthritis & Rheumatology
- Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
- (2013) R Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
- (2013) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
- (2013) Feng Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
- (2013) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
- (2013) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
- (2013) Xenofon Baraliakos et al. ANNALS OF THE RHEUMATIC DISEASES
- Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
- (2013) Peggy Jacques et al. ANNALS OF THE RHEUMATIC DISEASES
- Synovial Fibroblasts Directly Induce Th17 Pathogenicity via the Cyclooxygenase/Prostaglandin E2 Pathway, Independent of IL-23
- (2013) S. M. J. Paulissen et al. JOURNAL OF IMMUNOLOGY
- KIR3DL2 Binds to HLA-B27 Dimers and Free H Chains More Strongly than Other HLA Class I and Promotes the Expansion of T Cells in Ankylosing Spondylitis
- (2013) I. Wong-Baeza et al. JOURNAL OF IMMUNOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1
- (2013) Yohei Kirino et al. NATURE GENETICS
- Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
- (2013) Adrian Cortes et al. NATURE GENETICS
- Genetic insights into common pathways and complex relationships among immune-mediated diseases
- (2013) Miles Parkes et al. NATURE REVIEWS GENETICS
- Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification
- (2012) Walter P Maksymowych et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
- (2012) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis
- (2012) Nigil Haroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis
- (2012) Lihi Eder et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
- (2012) Ejaz Pathan et al. ANNALS OF THE RHEUMATIC DISEASES
- Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies
- (2012) Irene E van der Horst-Bruinsma et al. ANNALS OF THE RHEUMATIC DISEASES
- The development of LTi cells
- (2012) Marie Cherrier et al. CURRENT OPINION IN IMMUNOLOGY
- Radiographic progression in ankylosing spondylitis/axial spondyloarthritis
- (2012) Denis Poddubnyy et al. CURRENT OPINION IN RHEUMATOLOGY
- Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis
- (2012) Zaiying Hu et al. International Journal of Rheumatic Diseases
- HLA-B27 Homodimers and Free H Chains Are Stronger Ligands for Leukocyte Ig-like Receptor B2 than Classical HLA Class I
- (2012) J. Giles et al. JOURNAL OF IMMUNOLOGY
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- The role of IL-17-secreting mast cells in inflammatory joint disease
- (2012) Tony J. Kenna et al. Nature Reviews Rheumatology
- Epidemiology of Spondyloarthritis
- (2012) Carmen Stolwijk et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- IL-7: The global builder of the innate lymphoid network and beyond, one niche at a time
- (2012) Joonsoo Kang et al. SEMINARS IN IMMUNOLOGY
- New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
- (2012) Jacqueline Shaw et al. Frontiers in Immunology
- Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)
- (2011) M. Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis
- (2011) Praveena Chiowchanwisawakit et al. ARTHRITIS AND RHEUMATISM
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis
- (2011) Francesco Ciccia et al. ARTHRITIS AND RHEUMATISM
- Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition
- (2011) Fernando Kemta Lekpa et al. JOINT BONE SPINE
- Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis
- (2011) P. Bowness et al. JOURNAL OF IMMUNOLOGY
- Resolution of Inflammation Following Treatment of Ankylosing Spondylitis Is Associated with New Bone Formation
- (2011) S. J. PEDERSEN et al. JOURNAL OF RHEUMATOLOGY
- A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis
- (2011) Zhiming Lin et al. NATURE GENETICS
- Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
- (2011) David M Evans et al. NATURE GENETICS
- Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
- (2011) Heiner Appel et al. ARTHRITIS RESEARCH & THERAPY
- A strong familiality of ankylosing spondylitis through several generations
- (2010) A. J. Geirsson et al. ANNALS OF THE RHEUMATIC DISEASES
- Expression of T cell receptors αβ and γδ in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy
- (2010) C. A. CUVELIER et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Prostaglandin E2, an Immunoactivator
- (2010) Daiji Sakata et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis
- (2010) R. D. INMAN et al. JOURNAL OF RHEUMATOLOGY
- Undifferentiated Spondyloarthritis: A Longterm Followup
- (2010) P. D. SAMPAIO-BARROS et al. JOURNAL OF RHEUMATOLOGY
- Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
- (2010) John D Reveille et al. NATURE GENETICS
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- HLA-B27 Transgenic Rat
- (2009) Anna Franca Milia et al. Annals of the New York Academy of Sciences
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis
- (2009) F. W. L. Tsui et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials
- (2009) J Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats
- (2009) Monica L. DeLay et al. ARTHRITIS AND RHEUMATISM
- Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
- (2009) Francesco Ciccia et al. ARTHRITIS AND RHEUMATISM
- Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis
- (2009) Nick Barkham et al. ARTHRITIS AND RHEUMATISM
- Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation
- (2009) Walter P. Maksymowych et al. ARTHRITIS AND RHEUMATISM
- Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
- (2009) PH Schafer et al. BRITISH JOURNAL OF PHARMACOLOGY
- IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling
- (2009) H Huang et al. CELL DEATH AND DIFFERENTIATION
- A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
- (2009) Jaya Goswami et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
- (2009) Amit Awasthi et al. JOURNAL OF IMMUNOLOGY
- Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis
- (2009) B. DIJKMANS et al. JOURNAL OF RHEUMATOLOGY
- Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
- (2009) Désirée van der Heijde et al. ARTHRITIS RESEARCH & THERAPY
- Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index
- (2008) W P Maksymowych et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two
- (2008) Hildrun Haibel et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
- (2008) Robert D. Inman et al. ARTHRITIS AND RHEUMATISM
- Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis
- (2008) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
- (2008) D. van der Heijde et al. ARTHRITIS AND RHEUMATISM
- Interleukin-23: Immunological roles and clinical implications
- (2008) Zi Yan Tan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation
- (2008) O. B. Pedersen et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search